193 related articles for article (PubMed ID: 36347033)
1. Multilevel data integration and molecular docking approach to systematically elucidate the underlying pharmacological mechanisms of Er-Zhi-Wan against hepatocellular carcinoma.
Zheng S; Pan B
Aging (Albany NY); 2022 Nov; 14(21):8783-8804. PubMed ID: 36347033
[TBL] [Abstract][Full Text] [Related]
2. Exploring the mechanisms underlying the therapeutic effect of the
Qing L; Pan B; He Y; Liu Y; Zhao M; Niu B; Gao X
Aging (Albany NY); 2022 Nov; 14(22):9103-9127. PubMed ID: 36403263
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological Mechanisms Underlying the Hepatoprotective Effects of
Pan B; Pan W; Lu Z; Xia C
Evid Based Complement Alternat Med; 2021; 2021():5591402. PubMed ID: 34326886
[TBL] [Abstract][Full Text] [Related]
4. Effects of Er-Zhi-Wan on microarchitecture and regulation of Wnt/β-catenin signaling pathway in alveolar bone of ovariectomized rats.
Sun W; Wang YQ; Yan Q; Lu R; Shi B
J Huazhong Univ Sci Technolog Med Sci; 2014 Feb; 34(1):114-119. PubMed ID: 24496689
[TBL] [Abstract][Full Text] [Related]
5. Er Zhi Wan, an ancient herbal decoction for woman menopausal syndrome, activates the estrogenic response in cultured MCF-7 cells: an evaluation of compatibility in defining the optimized preparation method.
Xu H; Su ZR; Huang W; Choi RC; Zheng YZ; Lau DT; Dong TT; Wang ZT; Tsim KW
J Ethnopharmacol; 2012 Aug; 143(1):109-15. PubMed ID: 22710293
[TBL] [Abstract][Full Text] [Related]
6. Integrative multilevel exploration of the mechanism by which Er-Zhi-Wan alleviates the Parkinson's disease (PD)-like phenotype in the MPTP-induced PD mouse model.
Pan B; Niu B; He Y; Zhou C; Xia C
Biomed Pharmacother; 2023 Sep; 165():115021. PubMed ID: 37348406
[TBL] [Abstract][Full Text] [Related]
7. Integrated plasma and urine metabolomics coupled with HPLC/QTOF-MS and chemometric analysis on potential biomarkers in liver injury and hepatoprotective effects of Er-Zhi-Wan.
Yao W; Gu H; Zhu J; Barding G; Cheng H; Bao B; Zhang L; Ding A; Li W
Anal Bioanal Chem; 2014 Nov; 406(28):7367-78. PubMed ID: 25245419
[TBL] [Abstract][Full Text] [Related]
8. A traditional Chinese herbal preparation, Er-Zhi-Wan, prevent ovariectomy-induced osteoporosis in rats.
Cheng M; Wang Q; Fan Y; Liu X; Wang L; Xie R; Ho CC; Sun W
J Ethnopharmacol; 2011 Nov; 138(2):279-85. PubMed ID: 22001072
[TBL] [Abstract][Full Text] [Related]
9. Based on network pharmacology and experiments to explore the underlying mechanism of Mahonia bealei (Fortune) Carrière for treating alcoholic hepatocellular carcinoma.
Zhang N; Zhu Y; Zhang X; Yang K; Yang X; An M; Tian C; Li J
J Ethnopharmacol; 2024 Jan; 318(Pt A):116919. PubMed ID: 37453621
[TBL] [Abstract][Full Text] [Related]
10. Broad range metabolomics coupled with network analysis for explaining possible mechanisms of Er-Zhi-Wan in treating liver-kidney Yin deficiency syndrome of Traditional Chinese medicine.
Zhai Y; Xu J; Feng L; Liu Q; Yao W; Li H; Cao Y; Cheng F; Bao B; Zhang L
J Ethnopharmacol; 2019 Apr; 234():57-66. PubMed ID: 30690072
[TBL] [Abstract][Full Text] [Related]
11. Effects of a traditional Chinese herbal preparation on osteoblasts and osteoclasts.
Zhang H; Xing WW; Li YS; Zhu Z; Wu JZ; Zhang QY; Zhang W; Qin LP
Maturitas; 2008 Dec; 61(4):334-9. PubMed ID: 19004583
[TBL] [Abstract][Full Text] [Related]
12. Integrated System Pharmacology Approaches to Elucidate Multi-Target Mechanism of
Khalid HR; Aamir M; Tabassum S; Alghamdi YS; Alzamami A; Ashfaq UA
Molecules; 2022 Sep; 27(19):. PubMed ID: 36234758
[TBL] [Abstract][Full Text] [Related]
13. Systems Pharmacology-Based Strategy to Investigate the Mechanism of Ruangan Lidan Decoction for Treatment of Hepatocellular Carcinoma.
Chen C; Liang T; Wu Q; Zhou Z; Zhang M; Feng D; Tao J; Si T; Cai M
Comput Math Methods Med; 2022; 2022():2940654. PubMed ID: 36578460
[TBL] [Abstract][Full Text] [Related]
14. Network Pharmacology-Based Approach Combined with Bioinformatic Analytics to Elucidate the Potential of Curcumol against Hepatocellular Carcinoma.
Huang X; Rehman HM; Szöllősi AG; Zhou S
Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456457
[TBL] [Abstract][Full Text] [Related]
15. Identification of formononetin as the active compound of CR-SR in hepatocellular carcinoma treatment: An integrated approach combining network pharmacology and weighted gene co-expression networks.
Li C; Xie Y; Hu S; Yu H; Xu Y; Shen H; Yuan Y; Gu L; Pu B
Chem Biol Drug Des; 2024 Jan; 103(1):e14363. PubMed ID: 37793997
[TBL] [Abstract][Full Text] [Related]
16. Effect of gigantol on the proliferation of hepatocellular carcinoma cells tested by a network-based pharmacological approach and experiments.
Li S; Li H; Yin D; Xue X; Chen X; Li X; Li J; Yi Y
Front Biosci (Landmark Ed); 2022 Jan; 27(1):25. PubMed ID: 35090330
[TBL] [Abstract][Full Text] [Related]
17. Yupingfeng San exhibits anticancer effect in hepatocellular carcinoma cells via the MAPK pathway revealed by HTS
Pei T; Dai Y; Tan X; Geng A; Li S; Gui Y; Hu C; An J; Yu X; Bao X; Wang D
J Ethnopharmacol; 2023 Apr; 306():116134. PubMed ID: 36627003
[TBL] [Abstract][Full Text] [Related]
18. Network-Pharmacology-Based Study on Active Phytochemicals and Molecular Mechanism of
Khan SA; Lee TKW
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628212
[TBL] [Abstract][Full Text] [Related]
19. A large-scale transcriptional analysis reveals herb-derived ginsenoside F2 suppressing hepatocellular carcinoma via inhibiting STAT3.
Tan X; Ma X; Dai Y; An J; Yu X; Li S; Liao Y; Pei T; Tang Y; Gui Y; Zhou S; Guo D; Deng Y; Hu K; Wang D
Phytomedicine; 2023 Nov; 120():155031. PubMed ID: 37666060
[TBL] [Abstract][Full Text] [Related]
20. [Study on molecular mechanism of Solanum nigrum in treatment of hepatocarcinoma based on network pharmacology and molecular docking].
Liu JH; Lyu DY; Zhou HM; Kuang WH; Chen ZX; Zhang SJ
Zhongguo Zhong Yao Za Zhi; 2020 Jan; 45(1):163-168. PubMed ID: 32237426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
